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Abstract
Background: Since its inception, proteomics has essentially operated in a discovery mode with the goal of
identifying and quantifying the maximal number of proteins in a sample. Increasingly, proteomic measurements
are also supporting hypothesis-driven studies, in which a predetermined set of proteins is consistently detected
and quantified in multiple samples. Selected reaction monitoring (SRM) is a targeted mass spectrometric technique
that supports the detection and quantification of specific proteins in complex samples at high sensitivity and
reproducibility. Here, we describe ATAQS, an integrated software platform that supports all stages of targeted, SRM-
based proteomics experiments including target selection, transition optimization and post acquisition data analysis.
This software will significantly facilitate the use of targeted proteomic techniques and contribute to the generation
of highly sensitive, reproducible and complete datasets that are particularly critical for the discovery and validation
of targets in hypothesis-driven studies in systems biology.
Result: We introduce a new open source software pipeline, ATAQS (Automated and Targeted Analysis with
Quantitative SRM), which consists of a number of modules that collectively support the SRM assay development
workflow for targeted proteomic experiments (project management and generation of protein, peptide and
transitions and the validation of peptide detection by SRM). ATAQS provides a flexible pipeline for end-users by
allowing the workflow to start or end at any point of the pipeline, and for computational biologists, by enabling
the easy extension of java algorithm classes for their own algorithm plug-in or connection via an external web site.
This integrated system supports all steps in a SRM-based experiment and provides a user-friendly GUI that can be
run by any operating system that allows the installation of the Mozilla Firefox web browser.
Conclusions: Targeted proteomics via SRM is a powerful new technique that enables the reproducible and
accurate identification and quantification of sets of proteins of interest. ATAQS is the first open-source software
that supports all steps of the targeted proteomics workflow. ATAQS also provides software API (Application
Program Interface) documentation that enables the addition of new algorithms to each of the workflow steps. The
software, installation guide and sample dataset can be found in http://tools.proteomecenter.org/ATAQS/ATAQS.
html
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Proteomics aims at the comprehensive identification and
quantification of the proteins present in a biological
sample. Typical samples include lysates of cells, tissue
extracts, body fluids such as serum or plasma, or frac-
tions of complete proteomes such as organelles or sub-
cellular fractions. These samples usually contain
thousands to tens of thousands of different proteins and
their complete analysis has been technically challenging,
in spite of significant recent progress. Most proteomic
measurements have been carried out by mass spectro-
metry. Several strategies have been developed that all
involve the generation of a protein sample, the digestion
of the proteins, typically with trypsin, and the separa-
tion, ionization and mass spectrometric analysis of the
complex peptide samples. There are several strategies
for mass spectrometry-based experiments [1,2]. In the
most commonly used strategy, referred to as data
dependent analysis (DDA), shotgun proteomics or dis-
covery proteomics, the instrument samples specific pre-
cursor ions (molecular ions of intact peptides) from all
the precursor ions detected in a survey scan using a
simple heuristics. Even though the sampling rate on
modern mass spectrometers has increased considerably
over the last few years, for complex proteome samples,
the number of precursor ions detected in a survey scan
typically exceeds the number of selection and fragmen-
tation cycles in the instrument. Consequently, with
repeat analyses of identical or very similar samples, dif-
ferent subsets of peptides are identified, resulting in irre-
producible data sets.
Recently, a complementary proteomic workflow has
emerged that is based on the targeted analysis of a set
of predetermined proteins and peptides. This workflow
is based on a mass spectrometric method referred to as
selected reaction monitoring (SRM). It involves the
selection of proteotypic peptides [3,4] from the predeter-
mined protein set and the targeted selection of precur-
sor ions based on their mass to charge ratio, the
fragmentation of the precursor ions in the collision cell
of a QQQ mass spectrometer and the selective detection
of peptide-specific fragment ions. The detected fragment
ions derived from a specific precursor ion are referred
to as transitions [5]. The precursor ion mass and the
corresponding optimized set of transitions, along with
additional information such as the preferred charge
state of a peptide ion and the chromatographic elution
time of the peptide, constitute a specific and highly sen-
sitive assay for the detection of a particular peptide in a
sample. SRM-based mass spectrometry produces consis-
tent, reproducible and highly sensitive data sets that are
particularly important for comparison of protein profiles
across multiple samples, as is the case with biomarker
discovery and validation studies and in systems biology
where a biological system is analyzed in differentially
perturbed states [6,7].
Over the last decade, a rich environment of open
source and proprietary software tools has emerged to
support all aspects of shotgun proteomics. In contrast,
software tools to support the targeted, SRM-based work-
flow are still sparse. Previously published TIQAM [8]
software suites (TIQAM-digestor, TIQAM-peptidealtas,
TIQAM-viewer) were also designed to support SRM
workflow by generating transitions from in-silico diges-
tion, by connecting to peptideatlas for transition selec-
tion and by manual examination of SRM triggered MS2
spectra. However, TIQAM connection to PeptideAtlas is
limited when user wishes to prioritize peptides based on
weighted amino acide composition. TIQAM-viewer is
used for manual validation with assistant of MS2 spectra
that are acquired by SRM triggered MS2 and there is no
systematic method to classify “validated” vs. “not vali-
date”. Moreover, TIQAM is a single user desktop appli-
cation rather than deployable and sharing the data in
collaborative working environment. Similarly, Bertsch
et al. recently published an algorithm to predict proteo-
typic peptides, their fragmentation and retention time
using sequence information alone [9]. The recently pub-
lished Skyline [10], a window client application, provides
a way to build SRM methods based on the BiblioSpec,
NIST and GPM formats of spectral libraries. Skyline
also provides a quantification value by calculating the
area under the curve using CRAWDAD software [11].
However, it uses a single score (hydrophobicity value
from SSRCalc) to provide confidence in identification.
Similar to TIQAM, it’s a desktop application with man-
ual inspection for validation. As a complementary tool
to Skyline, AuDIT [12], which is a webserver application
running at the GenePattern website, provides further
statistical validation in quantification using user-pro-
vided quantification values of light and heavy transitions.
However, there is no open or commercial software that
supports the entire SRM workflow for multiple users
and that can interface with web browsers on a personal
computer as well as connect to institution-wide comput-
ing resources for high throughput data analysis. Here we
introduce a new open source software pipeline, ATAQS
(Automated and Targeted Analysis with Quantitative
SRM), which provides modules with algorithms that
collectively support all of the steps of the SRM assay
development and deployment workflow for targeted pro-
teomic experiments (Figure 1). ATAQS software is
designed to support multiple users at an institution.
ATAQS can be easily extended and customized by the
user with the addition of user-implemented algorithms
at any of the workflow steps. It also provides API for
Brusniak et al. BMC Bioinformatics 2011, 12:78
http://www.biomedcentral.com/1471-2105/12/78
Page 2 of 15connecting to existing web service tools for easy data
export and import to user’s institutional web-based
ATAQS application.
In this manuscript, we describe the following work-
flow steps of ATAQS that collectively support the rou-
tine application of SRM-based targeted proteomics
studies:
1. ATAQS system overview
2. Workflow overview
3. Target Protein set selection
4. Peptide transition selection
5. Addition of isotopic pair and decoy transitions
6. Identification of confirmed transitions
7. Publication of verified transitions
In the section ‘ATAQS application’, we will also illus-
trate the ATAQS workflow with SRM-based analysis of
synthesized yeast peptides and signaling kinase proteins
in a human cancer cell line.
The ATAQS software is essential for the implementa-
tion and wide dissemination of a targeted proteomic work-
flow and therefore, this software is expected to have wide
application in all fields of life science research that require
the high-throughput generation of hypothesis-based,
reproducible and highly sensitive proteomic datasets.
Implementation
ATAQS System Overview
ATAQS is written in Java and has a three-tier architec-
ture to serve multiple users throughout an institution.
ATAQS uses Google Web Toolkit (GWT) technology to
create client and server codes and Hibernate to handle
database transactions (Figure 2). The presentation tier
(Figure 2a) provides a graphic user interface for the
popular browser Mozilla Firefox. ATAQS utilizes
Figure 1 Summary of ATAQS workflow. ATAQS is composed of seven steps. The data flow is flexible in that the user can select which steps
they want to use in cases in which the whole pipeline is not used. For example, if the user has already generated and optimized the list of
transitions and decoy transitions, then the user can skip steps 4 and 5. In each step, there are major options for user to select or define. In step
1, the experiment needs to be annotated by selecting exact mass spectrum instrument and organism. Also, the user can select other researchers
who can share the project. In step 2, the user needs to provide or select a list of proteins. In step 3, the user can explore the selected proteins’
properties and interactions by using PIPE2. Then, the user can extend the protein list or trim it down to a smaller number of proteins. In step 4,
the user needs to define what type of peptides and transitions to be selected for a given protein by specifying penalties of amino acid
compositions and fragment ion types. In step 5, the user will select to generate a decoy or heavy/light pairs based on user-selected decoy
generating algorithms and labeling methods. In step 6, mzXML or mzML format of measured data set is selected and the user groups the
experiments by transition list. Then, user can also select transition property measuring algorithm in this step. Based on the results of step 6, the
user can choose a FDR cutoff to determine validated peptides in a given sample. In step 7, as an option, the user can create a TraML format of
verified transitions to share with the community.
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Page 3 of 15Firegoose [13] in the business logic tier (Figure 2b) to
connect to web-based service sites, representing the data
storage and processing tier, (Figure 2c) such as PIPE2
(Protein Information and Property Exploration) [14] and
PeptideAtlas [15] in order to utilize both in-house devel-
oped algorithm support, public databases and processing
servers. Since ATAQS was designed to serve multiple
users, it has a light version of LIMS to organize project
lists and status by a given user and also to enable shar-
ing of projects among user-specified members.
W h e nau s e ri sl o g g e di na sa na d m i n i s t r a t o r ,t h e
admin page will be displayed (Additional File 1: Admin
section). The admin page allows the administrator to
add users, a list of available organisms and types of
mass spectrometers. When the admin chooses to add a
mass spectrometer, ATAQS opens a current list of mass
spectrometers from the EBI website (http://www.ebi.ac.
uk/ontology-lookup) to acquire the standard description
for the instrument.
The list of projects and their status for a logged-in
user are indicated in the Projects panel on the left side.
Shared projects from other members are read-only pro-
jects for the logged-in user. When logged in, the user
can use the ‘share’ button, and ATAQS will list available
Figure 2 ATAQS System Overview. The ATAQS system is composed of three tiers: (a) shows a presentation tier. User interface ATAQS using
Mozilla FireFox browser in any computer that can connect to ATAQS server. (b) illustrates a business logic tier. Servlet Coordinates the
applications, by launching processing modules in processing system and interface with Database to store/retrieve data (c) illustrates the data
storage and processing tier. Data are stored and retrieved and CPU heavy processing modules are running in a distributed CPU node system for
high throughput.
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selected or created project in the project setup step
(Additional File 1: Project setup section).
Workflow Overview
ATAQS has six panels. First, the user will start with the
‘Project Setup’ panel to describe the project, and define
the organism under study and the type of mass spectro-
meter used. Then, the user populates the protein list
from a user-defined list or an institution-wide database
in the ‘Generate Protein List’ panel. Optionally, the user
can refine the candidate protein list using the ‘Validate
Protein List’ panel. From the final list of proteins, pro-
teotypic peptides, which are unique sequences for a pro-
tein and also typically observed by MS, and the
corresponding transitions for each targeted peptide are
obtained from the ‘Generate Transition List’ panel.
Given the transition list and type of mass spectrometer
specified for the measurement, ATAQS offers a selec-
tion of algorithms to generate a score and error estimate
to measure the accuracy of the transition identification
in ‘Validate Transition List’. Finally, the user can choose
to create a proteomics standard initiative format of the
verified transition, referred to as TraML (Transition
Markup Language) [16], through which generated tran-
sitions and data can be easily published or transferred to
a public MRM transition website.
Target protein selection and validation
SRM is typically used to measure candidate protein bio-
markers or proteins for which are targeted in biological
studies based on prior knowledge of the system, e.g.
proteins for which the corresponding mRNA transcripts
have been identified as being differentially expressed in
transcriptome analyses of samples in different states.
Therefore, the first task of ATAQS is to acquire a pro-
tein candidate list and to optimize the list by filtering or
adding proteins to the initial candidate list. This optimi-
zation is accomplished by integrating other pertinent
information for the proteins on the initial target list
such as protein-protein interactions, cellular functions
or associations with signaling networks. The user can
upload their own protein list in the ‘Generate Protein
List’ step or use administrator-installed databases which
are available for all users of the institution, or merge
user-based lists with available databases.
Currently, ATAQS provides three curated disease-
specific protein candidate lists: (1) Prostate tumor, con-
taining 1055 proteins, (2) Type II diabetes, containing
954 proteins and (3) Breast cancer-related human kinase
signaling, containing 32 proteins. The prostate tumor
and type II diabetes protein databases are bioinformati-
cally curated using Medgene and the NIC GEO (Gene
Expression Omnibus) Microarray differential expression
analysis and human protein-protein interaction map
from HPRD (Human Protein Reference Database).
Numerous studies have confirmed the dysregulation of
protein kinases in several disease, in particular cancer
[17]. Based on the results of previous experiments and
the current literature, we selected 32 protein kinases to
target via SRM in the context of a breast cancer profil-
ing study.
The protein list from ‘Generate Protein List’ (or the
uploaded user-defined protein list) can be exported to
the PIPE2 website. PIPE2 includes various pipelets such
as ID Mapper and network visualization that allow users
to filter or add proteins from the protein list broadcast
by the ATAQS ‘Generate Protein List’ step. Figure 3
illustrates the PIPE2 network visualization. The curated
protein list can be broadcast back to ATAQS and is
listed in the ‘Validate Protein List’ panel. This optimized
or refined target protein list is the basis for the follow-
ing targeted proteomic analyses.
Peptide transition selection
Given a refined/optimized protein list, the next step is
to obtain proteotypic peptides for each protein. The
proteotypic peptide set can be defined as a unique pep-
tide set that can be used to unambiguously identify the
target set of proteins in biological samples. Desirable
proteotypic peptides are sequences unique to a given
protein that are also observed by mass spectrometry
with MS2 spectra that can be assigned to the respective
peptide sequence with high confidence. Thus, ATAQS
relies on PeptideAtlas, which contains millions of identi-
fied spectra to obtain proteotypic peptides and the cor-
responding transition selections. The PABST (Peptide
Atlas Best SRM Transition) webpage generates the opti-
mal peptide and transition lists.
PABST performs two sequential selections based on
user-defined criteria. First, peptides are selected primar-
ily based on the likelihood of observation and the pre-
sence or absence of various sequence features. To
address the former, we first query the PeptideAtlas data-
base and find all peptides mapping to a subject protein
that have been observed more than once. We also gen-
erate a list of all possible tryptic peptides from this
same protein (in silico digestion using TIQAM), and
apply two separate peptide detectability algorithms, Pep-
tide Sieve and Peptide Detectability Predictor. If the
empirical proteotypic score is available, it will be used,
otherwise, the theoretical proteotypic score is assigned.
The peptide is then evaluated based on user-defined cri-
teria, such as number of amino acids (peptide length),
amino acid composition and uniqueness of sequence
(does not map to more than one protein or one region
in the genome). A user-weighted factor score is then
calculated and the final score is calculated by combining
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factor score. The list of peptides is sorted by this score
in descending order and the user-defined number of
peptides is selected.
The next step is to generate a transition list. The best
fragment ions for a given peptide are obtained in this
step. First, SRM-verified transitions are deposited in
MRM PeptideAtlas [18], which contains data from both
the literature and from user submissions. If the
requested number of transitions for a given peptide has
not yet been met, the process looks at data from con-
sensus spectral libraries, as these have information
about which fragment ions are known to be generated
in CID, as well as their relative intensities. If a triple
quadrupole (QQQ) library is available, it is scanned first
for the peptide of interest. Next, a QTOF library is con-
sulted, if available, followed by an ion-trap library,
which is generally the most complete. For a given spec-
trum that matches the subject peptide, peaks are taken
in order of descending relative intensity. If there are no
observed spectra for the subject peptide or the mini-
mum number of requested transitions has not been met,
additional theoretical fragments are determined based
on TIQAM in silico digestion, which populates the list
first with singly charged y-ions with m/z greater than
precursor m/z, then with Y ions less than precursor m/
z, and finally with B ions, if necessary. As more verified
transition are deposited in the MRM PeptideAtlas, more
transitions will be observed and retrieved in this step for
a given mass spectrum. Figure 4 shows the PABST link
from the ATAQS protein list broadcast.
Alternatively, the user can download transitions
broadcasted from PABST to their desktop and add or
modify peptides (e.g., PTMs or other modification pep-
tides) and its related transitions. Then, the user can
upload the extended transition list to the transition
selection step by selecting the “Upload transitions from”
option instead of the “Get transitions From: MRMPepti-
deAtlas” option.
It’s also worth noting that MRM PeptideAtlas will
have an option available in the near future for user’st o
choose instruments for selecting transitions along with
the algorithm describe above (QQQ type first, then
QTOF, etc.).
The final transition list is sent back from the PABST
website to ATAQS by Firegoose. PABST is a public
website with a fixed URL, while ATAQS is an institute-
owned web application, rather than a web-based service
outside of the institute’s firewall (unless established as
such by the administrator). Therefore, the user must
add the ATAQS URL to receive the results (Additional
File 1: Setting up connection to other website section).
As an additional step, users can download the verified
transitions generated in this step and can further opti-
mize the transitions using their instrument setting. The
confirmed transitions then can be uploaded back to this
step to repopulate the transition for the following step.
Adding isotopic pair and decoy transitions
It is common to use internal standards consisting of
stable isotope-labeled reference peptides in the SRM
workflow. These reference compounds facilitate accurate
quantification and are useful for increasing the confi-
dence in detecting the targeted peptides in complex
samples. ATAQS provides a way to append various iso-
topic pair transitions to the given transition list in the
Figure 3 PIPE2 connection. ATAQS provides an automatic connection to the PIPE2 web server. Figure (a) shows the location of the simple
button to activate the PIPE2 connection and (b) illustrates the network viewer in PIPE2 for protein-protein interactions associated with the
protein list from ATAQS using HPRD.
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ATAQS uses the mProphet [19] validation algorithm
which requires both a decoy transition measurement
and the true target transition measurement to distin-
guish between true and false identifications of the tar-
geted peptides. Therefore, after candidate peptides and
transitions are obtained from PABST or via user uploads
from other sources, there is an option to expand the
transition list by adding user-specified isotope pair and
decoy transitions. The current distribution of ATAQS
provides two algorithms for generating decoy transi-
tions. One is called ‘Simple Algorithm’ by which decoy
transitions are generated using reversed peptide
sequence and transitions based on the TIQAM-Digestor
algorithm. Then we filter the decoy transitions by the
same ion type and select the closest Q3 m/z value of
the target transition. The recommended algorithm is
called ‘Simple - No Overlap Algorithm’ by which decoy
transitions are first generated in the same way as with
‘Simple Algorithms’, but then we add 10 Thomson to
the decoy Q1 values. This approach generates the same
number of decoy transitions and target transitions. The
combined transitions and decoy transitions can be
downloaded to the desktop of the user for consecutive
mass spectrometry runs.
Identification of confirmed transitions
The ‘Validate Transition List’ panel in ATAQS requires
mzXML or mzML files from an SRM mass spectrometry
run, along with a transition list that is generated by
ATAQS. When transitions are measured across various
background samples (e.g., different patients or different
 
 
 
 
 
 

Figure 4 Transition list. ATAQS sends the protein list to the Peptide Atlas Best SRM Transition website and generates the best peptide set
based on an empirical score that uses a user-defined penalty weight. For example, the user can increase the penalty value to 2 to avoid a
methionine in the peptide sequence.
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Page 7 of 15growth conditions for cells, etc.), the transitions need to
be grouped according to the run ID. An example of a
run ID assignment is explained in the case study section
‘ATAQS application’. The trace for each detected transi-
tion is extracted and smoothed using DFT (Discrete
Fourier Transformation). The smoothed transition traces
a r et h e nu s e db yt h e‘transition group algorithm’ to
select the best peak group called in ATAQS. For a given
peptide we detect all transitions that belong to the pep-
tide (Q1) and detect all the peaks of each transition that
are above background noise. There are several transition
peaks in a given transition trace. Each peak of a transi-
tion trace is then grouped with the nearest peak of the
entire transition set for a targeted peptide. Then, for
each peak group, the values of the following properties
are calculated: (1) sum intensities, (2) retention time
deviation, and (3) number of transitions in a peak
group. Based on the ranked score of the three property
values, the best transition peak group is selected. Figure
5 illustrates an example of a transition set of a given
peptide after applying smoothing algorithms and also
indicates our correct peak group selection over strongly
interfering transition peak groups. The selected best
peak group of a specified peptide is then used to
calculate the following classifiers for further discrimi-
nant analysis: (1) sum total intensities in log2 scale, (2)
dot product of heavy and light pair, (3) standard devia-
tion of retention time, (4) deviation from expected
retention time, (5) number of detected heavy transitions,
(6) number of detected light transitions and (7) number
of matched heavy and light pair transitions used in the
dot product calculation. The seven peak group property
values of the best peak group per peptide are used as
‘features’ for the semi-supervised learning approach
implemented in mProphet. The sum of the intensity
values is used as the main feature and the other six
values are used as secondary features. The entire set of
t r a n s i t i o n si sd i v i d e di n t oa training set and a test data
set using 10-fold cross validation. Then, the linear dis-
criminant analysis (LDA) finds the linear combination of
features that best separates the target transitions and
decoy transitions using the training dataset. A null dis-
tribution of false peak group identifications is estimated
from the decoy data points. The weight of this distribu-
tion is estimated based on the left part of the target dis-
tribution in the region where almost only false
identifications are expected. Based on this null distribu-
tion, a false discovery rate in dependence of the chosen
Figure 5 ATAQS validator. The ATAQS validator best peak group selection algorithm is capable of selecting the correct peak group when a
strong false interference peak group is present.
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transition discriminant score distributions, FDR and sen-
sitivity curve and ROC.
Publishing verified transitions
For hypothesis-driven proteomics, SRM technology can
be a robust and simple assay method to verify the detec-
tion and accurate quantification of proteins in various
biological samples if there are known verified and opti-
mized transitions available for the set of candidate pro-
teins. However, optimization and validation of a
transition set that corresponds with the proteins of
interest can be labor-intensive and time-consuming.
Therefore, we developed a model of ATAQS to auto-
mate the optimization and validation of transitions,
thereby making this a high-throughput process. We
expect that generating verified transitions for any pro-
tein can be a joint effort within the LC-MS-based pro-
teomics research community. We worked with the
HUPO PSI (proteomics standard initiative) to define a
file format that can be widely accepted for better
exchange of verified information. We proposed the
TraML (Transition Markup Language) schema to PSI
and it is currently under review. The TraML schema
captures transition information from both small mole-
cules metabolomics and from proteomics communities.
The most recent information on TraML development
can be found at http://psidev.info/index.php?q=node/
405.
ATAQS also provides an easy way to create and pub-
lish user-verified transition lists in the ‘Publisher Veri-
fied Transition List’ step. ATAQS collects some basic
required information such as author contact, etc. and
automatically creates a TraML file for users to review
(Additional File 1: Publishing validated transitions sec-
tion). The TraML file contains user-verified transitions
for the selected project by selecting a cutoff discriminant
score. Then, the user can upload the reviewed TraML
file and use the ‘publish’ button in order to upload the
TraML file to the MRM PeptideAtlas.
The above section describes the seven ATAQS steps
that guide biologists or analytical chemists through the
SRM experimental workflow. We attempted to make the
ATAQS software architecture user-friendly, not only to
users of the GUI (graphical user interface), but also to
computational biologists who would like to add their
own algorithms. New algorithms or modules can be
written in java or other programming languages that
can be executed by servlet executor codes. The detailed
information regarding the servlet classes that are needed
for an additional algorithm is provided in the ATAQS
installation guide and software API documentation.
When the system admin adds new extended algorithms
to the server, the ATAQS GUI option will populate the
new algorithm automatically. For the power users, it’s
worth noting that the CPU-intensive modules can be
run by command line Linux shell scripts generated by
ATAQS servlet codes. ATAQS servlet executors distri-
bute the CPU intensive modules to many different
nodes, and these modules are referred to as the ‘spun
off processing modules’ in Figure 2.
Results and Discussion
ATAQS also provides a flexible workflow so users can
start and end at any of the seven steps. More specifi-
cally, the user can just use the transition validation step
or just use the protein validation step. The following
case studies highlight this flexibility of ATAQS, its
mode of operation and its performance. The first exam-
ple of the use of synthetic yeast peptides for SRM mea-
surements illustrates the steps used to generate and
validate transitions in the ATAQS pipeline, and the sec-
ond example concerns the measurement of protein
kinases in a human breast cancer cell line.
Applying a subset of steps from ATAQS for detecting
synthetic yeast peptides in a complex peptide matrix
The ‘Validate Transition List’ step is one of the critical
steps for high throughput generation of verified transi-
tions. In an effort to develop algorithms and software
for describing the properties of each transition and for
performing the statistical analysis, we prepared a test
case study in which a set of chemically synthesized pep-
tides of known sequence was diluted into a complex
peptide background. Each target peptide was synthesized
in isotopically heavy and light form to generate a dis-
tinctive transition signature for the discrimination of
true from false signals.
One hundred proteotypic yeast peptides were selected
and synthesized in heavy and light form by JPT Peptide
Technologies, Inc [20]. Using the ‘Transition Generator
Panel’ in ATAQS, the user can perform the fourth (Pep-
tide transition selection) and fifth (adding isotopic pair
and decoy transitions) steps described in the method
section. Thus, for each peptide, five transitions were
selected from the MRM PeptideAtlas, totaling 500 tran-
sitions that are based on MS2 data generated on an
ABSCIEX 4000 instrument. Then, using the transition
generator, the heavy pair transitions for the 500 transi-
tions were added and a matching number of decoy tran-
sitions were added to the transition list, as described in
the ‘Adding isotopic pair and decoy transition’ section.
The resulting 2000 transitions were then downloaded to
the user’s desktop from ATAQS and divided into four
sets of 500 transitions each. These transitions were mea-
sured on an ABI-Qtrap 4000 in SRM mode in samples
containing the targeted peptides in three concentrations
(1x, 4x, 64x) in three different complex peptide
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Page 9 of 15backgrounds consisting of N-glycopeptides isolated from
human plasma and tryptic digests of C. elegans and Lep-
tospira interrogans extracts, respectively. In total, 36 (3
biological backgrounds, 3 step dilution series times 4
sets of 500 transition lists) LC-MS SRM experiments
were performed.
The acquired data from all 36 samples were converted
to mzXML and uploaded to a server along with the
2000 transition list file generated by ATAQS to the
‘Validate Transition List’ panel in ATAQS. The user
then assigned 9 sample IDs based on the four LC-MS
runs using the four subsets of the 2000 transitions list.
More specifically, one dilution with one biological back-
ground was measured with the four subsets of the origi-
nal 2000 transitions, resulting in four mzXML files. The
four mzXML files were then assigned one run ID. As
described in the ‘identification of confirmed transitions’
method section, the best transition peak group was
determined for each measured peptide. Therefore, there
were nine (3 different background times 3 dilutions)
measurements for a target peptide in this example (nine
Sample IDs). The best transition peak group list of
18000 transition measurements (9 samples times 2000
transitions) was generated and analyzed for statistical
validation analysis. The summarized results are dis-
played in ATAQS in chart format with FDR and sensi-
tivity curve and ROC (Figure 6). Figure 6(a) illustrates
the good separation of target and decoy transitions.
From the chart in Figure 6(b), the user can use the dis-
criminant score cutoff of -1 to obtain a 5% FDR level.
The 18000 transition list along with discriminant score
can be downloaded to the user’s desktop from the
ATAQS ‘Validate Transition List’ step.
Figure 5 shows the correctly identified transition
groups from this yeast experiment. This example illus-
trates how the user can confidently identify transitions
from ambiguously identified transitions for a given FDR.
The discriminant score of the100 peptides in each of
the nine samples are provided at http://tools.proteome-
center.org/ATAQS/ATAQS.html.
Applying ATAQS for detecting kinase proteins in a human
breast cancer cell line
The second example set was prepared to target 50 pep-
tides from 32 protein kinases in tryptic digests of
extracts of the T-47D human ductal breast epithelial
tumor cell line. The cell line was grown and lysed and
the lysate was digested with trypsin. Fifty heavy-labeled
reference peptides corresponding to PTP’so ft h et a r -
geted kinases were spiked into the total cell lysate. Sam-
ple sets containing 2 μg digested protein mass and 8, 40
and 200 fmol of each of the isotopically labeled refer-
ence peptides were measured in triplicate. The kinase
protein list is also included in the ATAQS database.
The project description was annotated in the ATAQS
‘Project setup’ and the protein list was populated in the
‘Generate Protein List’ step. We also investigated the
candidate protein list in the context of protein networks
using PIPE2 (Figure 3). PIPE2 provides utilities to
explore functionalities, cellular location and protein-
protein interaction for the candidate kinase proteins and
notes additional protein candidates which can be pur-
sued in future studies, e.g. by targeting mass spectrome-
try. The PIPE2 analysis indicated that our selected
candidate proteins are associated with known cancer
genes (e.g., BRCA). Eight to ten transitions were selected
and equal amounts of decoy transitions were added.
A total of 1896 transitions were divided into four transi-
tion sets. A total of 36 LC-MS SRM experiments (3 dilu-
tions times triplicate runs times 4 sets of transitions)
were performed. Both datasets were measured using the
ABSCIEX 4000 QTRAP mass spectrometer. Human
protein kinases were targeted by SRM from total human
cell lysate and the data were analyzed using the entire
ATAQS workflow.
T h ed a t aa n a l y s i st o o k2 5m i n u t e s( i n c l u d i n gC P U ,
low activity system and IO) with a 2.33 GHz and 4 GB
RAM hardware platform. Figure 7 shows the graphical
summary reports for the kinase dataset. Compared to
the synthetic light and heavy controlled yeast experi-
ment, using a more complex and ‘real’ sample such as a
cell line and a particularly challenging target protein
group resulted in a less complete separation of decoy
and target transitions. Figure 8(a) and 8(b) show the
ATAQS-identified transitions guided by heavy pair tran-
sitions, even when there was strong interference in the
transitions. Figure 8(c) illustrates a case where a decoy
transition made it through with the FDR cutoff of 1.2%.
With an FDR cutoff of 1.2%, 215 out of 450 peptides
(50 peptides in nine cell line samples) were classified as
correctly identified. Overall, the 215 identified peptides
led to the detection of 41 out of 50 kinases in the tryptic
digest of a human cell line subjected only to single
dimensional chromatographic separation. The full list of
450 peptides in each sample, along with the score and
associated error rate data, are provided at http://tools.
proteomecenter.org/ATAQS/ATAQS.html.
Conclusions
As a complement to the well-established discovery pro-
teomic methods, targeted mass spectrometry based on
SRM is becoming an important tool for the generation
of reproducible, sensitive and quantitatively accurate
data from biological samples. The method depends on
the generation of target protein sets based on prior
information and the one-time generation of verified
mass spectrometric assays for each of the targeted pro-
teins. The development of these assays depends on the
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Page 10 of 15optimal selection of peptides that represent the proteins
on the target list and the optimal set of transitions for
their detection in biological samples. Once developed,
these assays can be continually applied across a multi-
tude of studies.
The ATAQS pipeline and software provides a high
throughput tool for organizing, generating and verifying
transition lists and for the post acquisition analysis and
dissemination of the data generated from applying the
transition lists to studies of biological samples. ATAQS
Figure 6 Statistical Summary. ATAQS provides a graphical summary report. This figure illustrates the results from the yeast 18000 transition
SRM measurements. (a) shows the separation of decoy and target transition distributions by a semi-learning algorithm and (b) shows the FDR
and sensitivity curve with respect to the discriminant score cutoff. (c) shows the ROC curve for the data.
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Page 11 of 15uses information from publicly accessible databases for
the optimization of the protein and peptide target lists
and for the optimization of a transition set. ATAQS is
an open source software that enables hypothesis-driven
research by providing the capability to generate candi-
date protein lists and measure candidate proteins across
a large number of biological samples, and allows algo-
rithm-developing scientists to further develop the steps
in the ATAQS pipeline. For example, current ATAQS
contains two different methods to generate decoys and
to measure transition properties. GUI allows users to
select one of these algorithms. Thus, computational
biologists can extend the provided abstract class to add
their own algorithms for transition generation steps and
validation steps (Additional File 1: Plug-in your own
algorithms). As needs arise, we plan to continuously
expand on ATAQS functionalities (e.g., validation of
quantification, support of SILAC type experiments, etc.).
ATAQS is also available from Sourceforge.net (keyword
search:Corra-ATAQS).
We expect that ATAQS will find wide application as
targeted proteomics increases in use to support hypoth-
esis-driven research across all fields of life science.
Availability and Requirements
￿ Project name: ATAQS (Automated and Targeted
Analysis with Quantitative SRM)
￿ Project home page: http://tools.proteomecenter.
org/ATAQS/ATAQS.html and Sourceforge.net
under Corra-ATAQS project.
(a)                                                 (b) 
(C) 
 
 
 
 
 
 
 
Figure 7 Statistical summary of kinase dataset. ATAQS provides a graphical summary report. This figure illustrates the results from the kinase
transition SRM measurements. (a) shows the separation of decoy and target transition distributions by a semi-learning algorithm and (b) shows
the FDR and sensitivity curve with respect to the discriminant score cutoff. (c) shows the ROC curve for the data.
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Page 12 of 15Figure 8 Identified kinase peptide transitions in a cancer cell line. (a) shows the smoothed heavy and light transitions of the kinase peptide
AQLSTILEEEK in three different heavy peptide-spiked samples. (b) shows the kinase peptide IISIFSGTEK transitions. (a) and (b) show how ATAQS
calculates the properties described in the ‘identification of confirmed transitions’ guided peptide detection in the sample, in spite of the strong
interference. (c) shows an example of a decoy peptide RNVSTESIEF, which is above the FDR score cutoff of <1.2% in validation.
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Page 13 of 15￿ Operating System(s): Linux 2.6.18
￿ Programming language: Java, R. mysql
￿ Other requirements: Tomcat v 6.0.26 or higher,
Java 1.6, Ant v1.7.1, mysql v 5.0.77, Firefox 3.6.x,
Firegoose-0.8.259.xpi, Adobe Flash Player 10, R
2.11.1
￿ License: Apache 2.0
Additional material
Additional file 1: It is ATAQS’s step by step user guide using
example dataset provided for this manuscript.
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